Tele-Cross Education for severe stroke
Official title: Effect of Home-based Cross-education on Lower Limb Neuroplasticity in Severe Stroke
Run by University of Illinois Chicago · NCT07652970 · Data updated 2026-11-12
This study tests whether home-based, remotely guided training of the unaffected leg can help improve brain and nerve function and movement in people with severe stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | June 17, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT07652970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a single, chronic, severe unilateral stroke, adequate cognitive function, and the ability to use a tablet for remote supervision.
✕Probably not a fit
Patients with multi-territory brain injury, cognitive impairment below the required threshold, or significant comorbidities may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares two home-based programs delivered with remote supervision: Tele-Cross Education, which uses unilateral training of the unaffected leg, and Tele-control, which includes cognitive tasks and unilateral movements. Each participant undergoes both conditions with pre- and post-intervention assessments of brain activity, spinal measures, and motor function. The study aims to determine feasibility, participant acceptance, and potential neuroplastic and functional benefits in chronic, monohemispheric, severe stroke. Recruitment is limited to adults with chronic, severe unilateral stroke and adequate cognitive capacity, and it excludes individuals with confounding neurological conditions, significant language barriers, or certain medical or anatomical contraindications.
Why it matters
Potential benefit: If successful, this approach could offer a feasible at-home therapy option to enhance motor recovery after severe stroke.
How similar studies have gone: Previous research in neurorehabilitation supports the idea that cross-education and remote training can influence neuroplasticity and function, though this exact home-based Tele-CE approach is relatively novel for severe stroke.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Single, monohemispheric stroke * Chronic stroke (\> 6 months prior) * Severe stroke (Fugl-Meyer Lower Extremity motor scale score \< 21 or 6 Minute Walk Test distance \< 300m) Exclusion Criteria: * Use of anti-spasticity medications * Existence of other neurological disorders * Have brainstem or cerebellar lesions. * Mini-Mental State Examiniation score of \<21, to ensure participants have the cognitive capacity to consent and can understand instructions both in-person and during remote supervision. * Non-English-speaking individuals * Bone, joint or soft tissue injury * Uncontrolled medical conditions (such as uncontrolled hypertension, untreated cardiac disease, or untreated pulmonary disease) * Unable to see the tablet and zoom screen * Unable to move non-paretic ankle (\< 5 degrees of ankle ROM) * Fugl-Meyer Lower Extremity sensory scale score \< 6 TMS exclusion criteria * Previous adverse reaction to TMS * Skull abnormalities or fractures * Concussion within the prior 6 months * Unexplained, recurring headaches * Implanted cardiac pacemaker * Metal implants in the head or face * History of seizures or epilepsy * Use of medications that could alter cortical excitability or increase risk of seizure (e.g., antidepressants, antipsychotics, anxiolytics, anticonvulsants) * Current pregnancy PNS exclusion criteria * Skin hypersensitivity at any sites of stimulation, including the scalp, thoracolumbar spine, and peripheral limbs * History of contact dermatitis at any of the sites of stimulation * History of allodynia and/or hyperalgesia * Active skin infection * Skin lesions * Deep vein thrombosis * Any other skin or scalp condition that could be aggravated by stimulation * Implanted electronic, metallic, or highly conductive devices near site of stimulation that cannot be removed without permission from a health professional
Where it's running
-
Brain Plasticity Lab
Chicago, Illinois, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.